J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
At close: January 24 at 8:11:39 AM GMT+1 ...
Mr.P V Bhide, Dr.(Ms.)S Maheshwari, Mr.A Nadkarni. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback